Skip to content
Tenfell
Awarded contract
Published 18 Feb 2026

Support of existing Low Density Lipid (LDL) Removal Apheresis Systems

NHS Blood and Transplant · United Kingdom

Key facts

Contract value
£337,798
Awarded
20 Jan 2026
Contract starts
20 Jan 2026
Contract ends
19 Jan 2028
Procedure
Call-off from a framework agreement (framework)
Buyer type
Health

Awarded to

SupplierValue
Fresenius Medical Care (UK) Limited£337,798

Description

NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales. Requirement for support of existing Low Density Lipid (LDL) Removal Apheresis Systems.

Categories (CPV)

Similar open tenders

About NHS Blood and Transplant

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.